Bridgeway Capital Management’s Tempest Therapeutics TPST Stock Holding History

Bridgeway Capital Management’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-843	Closed	-$197K	–	1398
2021 Q1	$197K	Hold	843	–	–	﹤0.01%	1287
2020 Q4	$352K	Hold	843	–	–	0.01%	1074
2020 Q3	$268K	Hold	843	–	–	0.01%	1107
2020 Q2	$289K	Buy	+843	New	+$336K	0.01%	1054
2018 Q4	–	Sell	-51	Closed	-$109K	–	1459
2018 Q3	$109K	Sell	51 -86	-63%	-$207K	﹤0.01%	1379
2018 Q2	$363K	Hold	137	–	–	﹤0.01%	1214
2018 Q1	$324K	Hold	137	–	–	﹤0.01%	1188
2017 Q4	$560K	Buy	+137	New	+$575K	0.01%	1057
2017 Q1	–	Sell	-63	Closed	-$282K	–	1467
2016 Q4	$282K	Buy	63 +34	+117%	+$424K	﹤0.01%	1235
2016 Q3	$609K	Buy	29 +20	+222%	+$362K	0.01%	999
2016 Q2	$130K	Hold	9	–	–	﹤0.01%	1364
2016 Q1	$237K	Hold	9	–	–	﹤0.01%	1270
2015 Q4	$244K	Hold	9	–	–	﹤0.01%	1258
2015 Q3	$212K	Hold	9	–	–	﹤0.01%	1294
2015 Q2	$723K	Hold	9	–	–	0.01%	911
2015 Q1	$879K	Sell	9 -8	-47%	-$1.07M	0.02%	839
2014 Q4	$2.22M	Hold	17	–	–	0.05%	481
2014 Q3	$830K	Buy	17 +8	+89%	+$280K	0.02%	832
2014 Q2	$229K	Hold	9	–	–	0.01%	1311
2014 Q1	$226K	Hold	9	–	–	0.01%	1298
2013 Q4	$229K	Hold	9	–	–	0.01%	1276
2013 Q3	$248K	Buy	+9	New	+$319K	0.01%	1268

Other funds holding TPST

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

MIM

Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bridgeway Capital Management's TPST Position: Q2 2021 in Review

Bridgeway Capital Management sold out of Tempest Therapeutics (TPST) in Q2 2021, closing a stake of 843 shares — an estimated $197K sold.

Bridgeway Capital Management first reported a position in TPST in Q3 2013 and held it in 22 quarters. The position peaked at $2.22M in Q4 2014. 23 funds tracked by Wall St. Rank hold TPST as of Q2 2021.

Bridgeway Capital Management reported no remaining Tempest Therapeutics position as of Q2 2021 after selling out during the quarter.
Bridgeway Capital Management sold 843 Tempest Therapeutics shares in Q2 2021, an estimated $197K.
Bridgeway Capital Management first reported a position in Tempest Therapeutics in Q3 2013 and held it in 22 quarters.
Bridgeway Capital Management's Tempest Therapeutics position peaked at $2.22M in Q4 2014.
23 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2021.

Based on Bridgeway Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.